Company news

Vor Biopharma Inc. news in 2026

Vor Biopharma Inc.'s news releases, calls and decks from 2026, newest first.

View company

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 4, 2026

Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update

October 30, 2026

Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy

October 22, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

October 5, 2026

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

September 8, 2026

Vor Bio To Participate in Upcoming September Conferences

September 1, 2026

Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 11, 2026

Vor Bio Appoints David Zaccardelli to Board of Directors

July 7, 2026

Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

June 8, 2026

Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China

June 8, 2026

Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference

May 28, 2026

Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine

May 14, 2026

Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 13, 2026

Vor Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)

May 5, 2026

Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

March 29, 2026

Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease

March 29, 2026

Vor Bio Announces $75 Million Private Placement with TCGX

March 26, 2026

Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference

February 24, 2026

Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference

February 22, 2026

44th Annual J.P. Morgan Healthcare Conference Presentation (a19b30)

January 15, 2026

Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 6, 2026

Decks in 2026